Frauenärzte Am Schloss Borbeck
- Address
- Schloßstraße 174, 45355 Essen, Germany
Frauenärzte Am Schloss Borbeck - Women's Health Research Center
Frauenärzte Am Schloss Borbeck is a specialized women's health research center dedicated to advancing treatment options for female patients facing complex gynecological and oncological challenges. The center focuses on improving quality of life for women undergoing cancer treatment, with particular emphasis on managing therapy-related side effects.
- Vasomotor symptom management in breast cancer patients
- Hormone receptor-positive breast cancer treatment optimization
- Women's oncology and supportive care research
The center actively participates in clinical trials evaluating innovative therapies for vasomotor symptoms (VMS) such as hot flashes that occur as a result of adjuvant endocrine therapy. Their research contributes to developing better treatment strategies for women with hormone receptor-positive breast cancer and those at high risk for developing this condition, addressing the challenging side effects that can significantly impact patient compliance and quality of life during cancer treatment.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Frauenärzte Am Schloss Borbeck
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Elinzanetant in Treating Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy in Hormone-Receptor Positive Breast Cancer Patients | Bayer AG, Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Elinzanetant | 1 | Unknown | 2022-10-13 | 2022-10-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.